AI-generated summary
Forty-eight patients with solid tumors receiving 5-fluorouracil and doxorubicin were randomly assigned to one of four oral care approaches to prevent chemotherapy-induced oral mucositis. The authors report that 64.5% developed mucositis in the first cycle and that pain was significantly associated with severity. The intensive oral care program and low-level laser therapy showed potential preventive effects, though without statistical significance, and the authors call for larger studies.
- Participants
- 48
- Who or what was studied
- Immunocompetent adult patients aged 27 to 84 with solid tumors receiving 5-fluorouracil and doxorubicin chemotherapy
- Limits stated in the abstract
- The authors note the lack of statistical significance for the preventive effects and state that the approaches should be investigated in larger samples.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Oral mucositis, Low-level laser therapy, Statistical significance, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.